References
- Hoffken K, Price M R, McLaughlin PJ, et al. Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumors at various body sites. Int J Cancer 1978; 21: 496–504
- Jennette J C, Feldman JD. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas. J Immunol 1977; 118: 2269–2274
- Theofilopolous A N, Dixon FJ. Immune complexes associated with neoplasia. Immunodiagnosis of Cancer, RB. Herbermann. Marcel Dekker Inc., New York 1979; Vol II: 896–937
- Salinas F A, Wee K H, Silver H KB. Immune complexes and human neoplasia. Biomedicine 1983; 37: 211–218
- Gupta R K, Morton DL. Possible clinical significance of circulating immune complexes in melanoma patients. Fundamental Mechanisms in Human Cancer Immunology, JP Saunders, JC Daniels, B Serrous, C Rosenfeld, CB Denney. Elsevier North Holland, Inc., New York 1981; 305–320
- Dent P B, Louis J A, McCullock PB, et al. Correlation of elevated Clq binding activity and carcinoembryonic antigen levels with clinical features and prognosis in bronchogenic carcinoma. Cancer 1980; 45: 130–136
- Baldwin R W, Prince M R, Robins RA. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumor-bearer serum and solubilized hepatoma antigen. Int J cancer 1973; 11: 527–535
- Johnson P J, Williams R. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection. J Natl Cancer Inst 1980; 64: 1329–1332
- Tang ZY. A new concept of the natural history of AFP-positive hepatocellular carcinoma. Subclinical Hepatocellular Carcinoma, ZY. Tang. Springer-Verlag, New York 1985; 171–178
- Tang Z Y, Yang BH. Clinical evaluation of alpha fetoprotein as tumor marker for hepatocellular carcinoma. Chin J Oncol 1981; 3: 205–209
- Johnson P J, Portmann B, Williams R. Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding HCC. Br. Med J 1978; 2: 661–663
- McIntire K R, Vogel C L, Primack A, et al. Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with HCC. Cancer 1976; 37: 677–681
- Manger B J, Krapf F E, Gramatzki M, et al. IgE containing immune complexes in Churg-Strauss vasculitis. Scand J Immunol 1985; 21: 369–373
- Fust G, Kavai M, Szegedi GY, et al. Evaluation of different methods for detecting circulating immune complexes. An interlaboratory study. J Immunol Methods 1980; 38: 281–289
- Fields H A, McCaustland K A, Bradley DW, et al. Purification of acute phase anti-hepatitis A virus (HAV) IgM and development of an IgM solid-phase radiommunoassay for the detection of HAV. J Immunol Methods 1982; 51: 149–157
- McCarthy D, Goddard D H, Pell BK, et al. Intrinsically stable IgG aggregates. J Immunol Methods 1981; 41: 63–74
- Chen D S, Sung JL. Relationship of hepatitis B surface antigen to hepatocellular carcinoma. Cancer 1979; 44: 984–992
- Chen D S, Sung JL. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977; 40: 779–783
- Zubler R H, Perrin L H, Creighton WD, et al. Use of polyethylene glycol (PEG) to concentrate immune complexes from serum or plasma samples. Ann Rheum Dis 1977; 36: 23–26, Suppl
- Thomas H C, MacSween R N, White RG. The role of the liver in controlling the immunogenicity of commensal bacterial in the gut. Lancet, 1: 1288–1291
- Narumoto J. Studies on circulating soluble immune complexes of the liver disease. 7. Immune complexes in the clincial course and their ultracentrifugal analysis. Gastroenterol Jpn 1981; 16: 186–192